Document:

Sublicense Agreement between SPE and Philips

 Exhibit 10.69 
 SUBLICENSE AGREEMENT BETWEEN SPE AND PHILIPS 
 This Sublicense Agreement Between SPE and Philips (“Agreement”) is dated and made effective as of February 3, 2011 (the “Effective Date”) by and between ECL7, LLC, a
Delaware LLC, (“SPE” or “ECL7”) and Koninklijke Philips Electronics N.V., a company duly incorporated under the laws of The Netherlands, having its registered office in Eindhoven, The Netherlands and Philips Medical
Systems Nederland B.V., a private company with limited liability and a Philips Healthcare company, having its registered office and its principal place of business at Veenpluis 4-6, 5684 PC, Best, The Netherlands (acting jointly and severally and
hereinafter individually and collectively referred to as “Philips”). SPE and Philips are referred to individually as a “Party” and collectively as the “Parties.” 

RECITALS 
 WHEREAS, Luna Innovations Incorporated, a Delaware corporation, together with Luna Technologies, Inc., a Delaware corporation (acting jointly and severally,
individually and collectively) (“Luna”) and Hansen Medical, Inc., a Delaware corporation (“Hansen”) entered into that certain License Agreement Between Hansen and Luna (“Hansen-Luna Agreement”),
with an effective date of January 12, 2010, in which, among other things, Luna granted a license to Hansen to certain intellectual property related to fiber optic shape sensing or localization technologies. 

WHEREAS, Hansen and Philips entered into that certain License Agreement between
Hansen and Philips (“Hansen-Philips Agreement”), with a signing date of February 3, 2011, setting forth the terms and conditions governing, among other things, the grant of a license from Hansen to Philips to practice under the
patents and other intellectual property related to FOSSL Technology in certain medical fields. 

WHEREAS, as a necessary precondition of Philips obtaining the sublicense relating to
the Licensed Luna IP, the SPE was formed and established as a Delaware limited liability company pursuant to that certain Limited Liability Company Agreement of ECL7, LLC. 

WHEREAS, Hansen assigned and conveyed to SPE the Hansen-Luna Agreement in that
certain Assignment and License Agreement between Hansen and ECL7 dated as of February 3 , 2011 (“SPE-Hansen Agreement”). 
 WHEREAS, the Parties desire for SPE to sublicense certain rights relating to the SDOF Medical Robotics Field, Non Robotic Medical Devices Field, Orthopedics Field,
Vascular Non-Robotic Field and Endoluminal Non-Robotic Field, which the SPE has acquired under the assigned Hansen-Luna Agreement, to Philips such that Philips can fully exercise such rights as described in the Hansen-Philips Agreement in accordance
with the terms and conditions of the Hansen-Luna Agreement and this Agreement. 

WHEREAS, the Parties acknowledge and agree that this Agreement refers to and
references the Hansen-Luna Agreement and that such references are solely for convenience and ease of reference. It is the intent of the Parties that this Agreement is and shall remain separate and independent from the Hansen-Luna Agreement.

 NOW, THEREFORE, in view
of the terms and conditions described below and for other valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereto agree as follows: 

1.    
      Definitions 
 Unless otherwise defined in this Agreement and
solely for ease of reference and convenience, initially capitalized words and phrases shall have the meanings given to them in the Hansen-Philips Agreement, and such terms shall be incorporated herein by reference. 

2.    
      License Grants 

2.1        Sub-License of Luna IP. SPE shall pass-through to Philips and
its present and future Affiliates rights SPE acquired from Hansen under the SPE-Hansen Agreement, which were granted to Hansen by Luna under the Hansen-Luna Agreement dated January 12, 2010 in the Licensed Fields solely to the extent expressly
set forth herein. Accordingly, SPE hereby grants as follows: 
 2.1.1    SDOF Medical
Robotics Field. Subject to the terms and conditions of this Agreement and the provisions in Section 2.l(a) (and other applicable sections) of the Hansen-Luna Agreement, SPE hereby grants to Philips and its present and future Affiliates as
the sole sublicensee of SPE (except with respect to sublicenses for Hansen Products) a nonexclusive, worldwide, transferable (subject to Section 6.3 of the Hansen-Luna Agreement and Section 15 of this Agreement) sublicense under the Licensed
Luna IP to research, develop, make, have made, use, have used, import, sell, have sold and otherwise commercialize and exploit Products, in each case solely within the SDOF Medical Robotics Field. [***] 

2.1.2    Non-Robotic Medical Devices Field. Subject to the terms and conditions of this
Agreement and the provisions in Section 2.l(b) (and other applicable sections) of the Hansen-Luna Agreement, SPE hereby grants to Philips and its present and future Affiliates, as the sole sublicensee of SPE, a nonexclusive, worldwide,
transferable (subject to Section 6.3 of the Hansen-Luna Agreement and Section 15 of this Agreement) sublicense under the Licensed Luna IP to research, develop, make, have made, use, have used, import, sell, have sold and otherwise commercialize
and exploit Products, in each case solely within the Non-Robotic Medical Devices Field (which includes, for the avoidance of doubt, the Colonoscopy Non-Robotic Field). [***] 

2.1.3    Orthopedics Field; Vascular Non-Robotic Field. Subject to the terms and conditions
of this Agreement and the provisions in Section 2.l(c) (and other applicable sections) of the Hansen-Luna Agreement, SPE hereby grants to Philips and its present and future Affiliates, as the sole sublicensee of SPE, an exclusive, worldwide,
transferable (subject to Section 6.3 of the Hansen-Luna Agreement and Section 15 of this Agreement) sublicense (with the right to sublicense through one or multiple tiers) under the Licensed Luna IP to research, develop, make, have made, use,
have used, import, sell, have sold and otherwise commercialize and exploit Products, in each case solely within the Orthopedics Field and the Vascular Non-Robotic Field (i.e., Naked Sublicenses within such fields are allowed). Notwithstanding the
foregoing, the license granted in this Section 2.1.3 shall be nonexclusive with respect to any Licensed Luna IP that constitutes “Intuitive New Intellectual Property” as defined in the Intuitive-Luna Agreement. 

CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS 

 2.1.4    Endoluminal Non-Robotic Field. Subject
to the terms and conditions of this Agreement and the provisions in Section 2.1(d) (and other applicable sections) of the Hansen-Luna Agreement, SPE hereby grants to Philips and its present and future Affiliates, as the sole sublicensee of SPE,
an exclusive, worldwide, transferable (subject to Section 6.3 of the Hansen-Luna Agreement and Section 15 of this Agreement) sublicense (with the right to sublicense through one or multiple tiers) under the Licensed Luna IP to research,
develop, make, have made, use, have used, import, sell, have sold and otherwise commercialize and exploit Products in each case solely within the Endoluminal Non-Robotic Field (i.e., Naked Sublicenses within the Endoluminal Non-Robotic Field are
allowed). Notwithstanding the foregoing, the license granted in this Section 2.1.4 shall be nonexclusive with respect to any Licensed Luna IP that constitutes “Intuitive New Intellectual Property” as defined in the Intuitive-Luna
Agreement. 
 2.1.5    Clarification Regarding Nonexclusive Sublicense Rights. To be
clear, subject to the terms of the Hansen-Luna Agreement and Section 10 of this Agreement, SPE retains all rights to enforce the Licensed Luna IP in the SDOF Medical Robotics Field and the Non-Robotic Medical Devices Field, without any obligations
whatsoever to Philips with respect to enforcement in such fields. For the avoidance of doubt, SPE shall have the same obligations as Hansen under Article 12 of the Hansen-Philips Agreement. 

2.2        [***] 

2.2.1    [***]. 

2.2.2    [***] 

2.2.3    [***] 
 CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

 2.2.4    [***] 

2.2.5    [***] 

2.2.6    [***] 

2.2.7    [***] 

2.2.8    [***] 

2.3        [***] 

CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS. 

 2.4        Acknowledgement
Regarding Agreements Among Hansen, Luna and Intuitive and Between Hansen and Philips, and SPE and Hansen. Philips has reviewed the agreements provided by Hansen listed in Exhibit H of the Hansen-Philips Agreement. Based on these agreements,
Philips acknowledges as follows: The licenses granted under the Licensed Luna IP, pursuant to Section 2 of this Agreement, to the extent they include (or come to include) sublicenses under patents or Technology of a Third Party, shall be
subject to the terms and conditions of the agreement governing the license under which the sublicense is granted. Philips acknowledges and agrees that (a) the Licensed Luna IP was licensed to Hansen pursuant to the Hansen-Luna Agreement;
(b) the Hansen-Luna Agreement was transferred to SPE under the SPE-Hansen Agreement; (c) the Licensed Luna IP sublicensed to Philips hereunder is subject to the terms and conditions of the Hansen-Luna Agreement, the Development and Supply
Agreement and the Hansen-Philips Agreement; and (d) Philips agrees to comply with the terms and conditions of the Hansen-Luna Agreement and the Development and Supply Agreement as a sublicensee of SPE under the Hansen-Luna Agreement and with
the terms and conditions of the Hansen-Philips Agreement. Further, Philips acknowledges and agrees that the rights licensed to Philips hereunder shall be subject to the rights and licenses granted by Hansen to Intuitive pursuant to the
Hansen-Intuitive Cross License Agreement, subject to certain limited rights and licenses retained by and/or granted to Luna pursuant to the Hansen-Luna Agreement and the Development and Supply Agreement, and subject to certain rights of Hansen
pursuant to the Hansen-Philips Agreement. 
 Philips agrees to [***] due under Section 2.4 of the Hansen-Luna Agreement
with respect to any Licensed Luna IP sublicensed hereunder and subject to such Section 2.4, provided Philips has confirmed in writing that it wishes to be licensed under the respective third party IP and Philips agrees to cooperate with SPE in
connection with the procedures provided for in, and compliance with the terms of, such Section 2.4 for the licenses that Philips has acknowledged. If Philips does not confirm in writing that it wishes to be licensed under the respective third
party IP, or if Philips does not pay Philips’ share of such Third Party Payments therefor, such Third Party IP shall be excluded from the Licensed Luna IP for all purposes under this Agreement. 

2.5        Clarification Regarding Copyrights. With respect to Technology
licensed by SPE to Philips under this Agreement that includes software, works of authorship or copyrighted materials, such licenses shall include the right to copy, modify and make derivative works thereof (and the right to use any ideas, concepts,
algorithms and other information contained therein) within the fields and pursuant to the terms and conditions otherwise provided in this Agreement, regardless of when or whether provided or disclosed to Philips. The foregoing shall not be construed
to require the delivery or provision of any particular software (or source code), works of authorship or copyrighted materials except to the extent specifically provided in one or more separate written agreements between the Parties. 

CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS. 

 2.6        Reservation of
Rights. Except for the rights and licenses expressly granted to Philips hereunder, SPE retains all right, title and interest in and to, as between the Parties, all of SPE’s right, title and interest in and to the Licensed Luna IP. SPE does
not grant to Philips any rights or licenses in or to any patents, Technology or other intellectual property, whether by implication, estoppel, or otherwise, except to the extent expressly provided in this Agreement. 

2.7        Philips-Luna Agreement. Based on Philips’ representation
to SPE, SPE hereby consents and acknowledges that Philips entered into a springing direct license with Luna for Licensed Luna IP (i.e., a license from Luna to Philips for Licensed Luna IP (of the same scope as the license therefor under this
Agreement) which will become effective immediately without any further action by Philips, if and to the extent the Hansen-Luna Agreement is terminated, or if rejected by reason of any bankruptcy, insolvency, or other creditor arrangement or
proceeding commenced by or against Hansen or its Affiliates. SPE also consents and acknowledges that Philips may enter into its own development agreements with Luna in the Non-Robotic Medical Devices Field (as defined in the Hansen-Luna Agreement)
and the SDOF Medical Robotics Field, and that SPE consents to such agreements, subject to any rights it may have under the Hansen-Luna Agreement and the Development and Supply Agreement, [***] 

2.8        Services Agreements. The Parties acknowledge that certain of
the obligations of the SPE may be performed by Hansen pursuant to that certain Administrative Services Agreement, dated as of February 3, 2011, between the SPE and Hansen, which agreement sets forth that Hansen as a “servicer” may
perform certain services for the SPE set forth herein. In consideration of such services performed by Hansen, the SPE shall pay Hansen the actual costs and expenses of such services, plus a service charge. The SPE represents to Philips that the
terms and conditions of such services agreement are intrinsically fair and reasonable and substantially similar to those that would be available at an arm’s-length basis with third parties. 

3.          Payment. 

3.1        Initial Payment. At the Closing Philips shall pay to SPE
(subject to the terms and conditions of this Agreement) an initial non-refundable, non-creditable payment of [***]. Until such payment is made by Philips, no licenses granted under this Agreement shall be deemed effective. The Parties acknowledge
that Philips is required to make a separate initial payment of [***] in consideration of the rights granted with respect to the Licensed Hansen IP and the Purchased Hansen Patents under (and subject to the terms and conditions of) the Hansen-Philips
Agreement. 
 3.2        Product Payments. In further
consideration of the rights granted hereunder by SPE to Philips, Philips shall make a royalty payment in the form of a FOSSL Enabled Product Payment to SPE for each calendar year [***]. For all FOSSL Systems for which a FOSSL Enabled Product Payment
is due, the FOSSL Enabled Product Payments made in a given calendar year shall be an amount which is equal to [***]. FOSSL Enabled Product Payments shall be subject to the terms and conditions of Sections 3.4, 3.6, 3.9, 3.10, 3.14, and 3.15 of the
Hansen-Philips Agreement, mutatis mutandis, to refer to amounts due under this Section 3.2 and with references to Hansen interpreted as references to SPE. 

CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED
WITH RESPECT TO THE OMITTED PORTIONS. 

 3.2.1    Extension. If any Buy Back Period is
extended or tolled pursuant to Section 4.3 and/or Section 4.4 of the Hansen-Philips Agreement, the time period during which FOSSL Enabled Product Payments are due under Section 3.2 shall be extended with respect to that specific Licensed Field
for an amount of time equivalent to the amount by which any Buy Back Period is so extended or tolled. For avoidance of doubt, if the Vascular Buy Back Period is extended for six (6) months, the payment period of Section 3.2 would be
extended for six (6) months for sales in the Vascular Non-Robotic Field only. 

3.3        Naked (Sub) Licenses and Cross Licenses. 

3.3.1    If Philips or its Affiliates enters into a Naked License or Naked Sublicense based
on the FOSSL IP then Philips shall [***] Philips will notify SPE promptly, and in any event within thirty (30) days following the execution of any Naked License or Naked Sublicense, which will include a description of the terms of such license,
and will thereafter notify SPE within thirty (30) days of receipt of consideration therefrom, which will include [***] Out-Licensing Payments will be due within sixty (60) days of receiving an invoice for such payment. With each
Out-Licensing Payment, Philips shall provide SPE a written report specifying in reasonable detail the form of underlying revenue received or grant given and the calculation of any applicable exclusions specified in this Section 3.3. 

CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED
WITH RESPECT TO THE OMITTED PORTIONS. 

 3.3.2  If Philips or its present or future Affiliates
enters into a cross-license based on the FOSSL IP, and the FOSSL IP is material to the cross license, then Philips shall pay [***]. 
 3.4        Wiring Instructions. All payments by Philips to SPE under this Agreement shall be made by wire in U.S. Dollars to the account designated by SPE in
writing. 
 3.5        Reporting. Subject to the extensions
described in Section 3.2.1 above, within thirty (30) calendar days following [***], Philips shall submit to SPE (even in the event that no FOSSL Systems have been manufactured or sold) a Royalty Reporting Form, duly completed by an
authorized officer of Philips. Royalty reports shall start with the first calendar quarter after shipment of the first FOSSL System for commercial sale, and end with the reporting period that ends [***], subject to the extensions described in
Section 3.2.1 above. 
 3.6        Records. Philips shall
(and shall ensure that its Affiliates and their respective licensees and sublicensees, as applicable) maintain complete, true and accurate books of accounts and records reasonably sufficient for the purpose of determining the payments to be made to
SPE under this Agreement for at least [***] following the end of the calendar quarter to which they pertain. SPE may at its own expense audit such books of account limited to Philips’ (and its Affiliates’ and their respective
licensees’ and sublicensees’) sale of the FOSSL Systems and the revenue and Licensing Out Costs described in Section 3.3 at the place where such books are kept, in order to verify Philips’ royalty statements provided for in this
Article 3. Any such audit shall be conducted only once per calendar year per set of books, upon at least 21 days prior written notice and by an independent professional auditor reasonably acceptable to Philips and bound by written confidentiality
obligations, during normal business hours and in such a manner as not to interfere unduly with normal business activities. A copy of any report made by such auditor shall be delivered to Philips at the same time as such report is delivered to SPE.
No audit in respect of any royalty statement shall commence later than [***] from the date of such royalty statement, and only one audit shall be conducted in respect of any such statement, except that if any material errors or discrepancies are
uncovered during an audit, more audits shall be allowed until such material uncovered errors or discrepancies are resolved. Any materials created by the audit shall be treated by SPE and Philips as confidential information. 

CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS. 

 3.7        Reports in
General. Philips’ royalty statements and its accounting records shall be final and binding on SPE unless (a) written detailed objection to them is given to Philips by SPE within [***] from the date of the relevant statement and unless
any action or proceedings in respect of the same are commenced within twelve months from the date of such written objection, (b) an audit uncovers a material error or discrepancy or (c) such statements and records are the subject of fraud,
gross negligence or a breach of this Agreement. 

3.8        Confidential Nature of Reports. The Royalty Reporting Forms
provided by Philips to SPE under this Article 3 in writing and marked as Confidential shall be treated by SPE as confidential. 
 3.9            Timing; Late Payments. Together with submission of Philips’ Royalty Reporting Form, subject to Section 3.2,
Philips shall pay the corresponding FOSSL Enabled Payment due to SPE hereunder within [***] of receiving an invoice for such payment. Any undisputed amounts not paid when due under this Agreement shall automatically accrue interest from the date
when due until actually paid at a rate equal to the sum of [***] plus the prime rate of interest quoted in the Wall Street Journal (West Coast edition) calculated daily on the basis of a 365-day year, or if such edition is unavailable, a similar
reputable data source; provided, however, that in no event shall such rate exceed the maximum annual interest rate permitted under applicable law. For the avoidance of doubt, the accrual of interest shall not apply to the initial payment due under
this Agreement. 
 3.10          Taxes. In the event
that the governmental authorities of any country imposes any withholding taxes on payments made by Philips to SPE hereunder and requires Philips to withhold such tax from such payments, Philips may reduce the payment due by the amount of such tax.
In such event, Philips shall promptly provide SPE with tax receipts issued by the relevant tax authorities and with reasonable assistance in obtaining any credits for, and reductions to or exemptions from, such amounts. 

4.        Anti-Shelving Provisions. The licenses granted herein are subject to SPE’s
rights under Article 4 of the Hansen-Philips Agreement. The Parties acknowledge and agree that SPE has certain rights to receive non-exclusive licenses (and potentially exclusive licenses under certain conditions) and to terminate the licenses
granted under Article 2 of this Agreement and as set forth in Article 4 of the Hansen-Philips Agreement.  

5.        Source Code Escrow. In accordance with Section 5 of the Hansen-Philips
Agreement, SPE, Hansen, Philips and [***] (or, if [***] is not reasonably available, another reputable software escrow company to be mutually agreed by SPE, Hansen and Philips) shall enter into an escrow agreement governing the deposit and release
of the Source Code Materials described in this Section 5 (such agreement, the “Escrow Agreement”). The Escrow Agreement shall also govern the deposit and release of the materials within the definition of “Source Code
Materials” as defined in Section 5 of the Hansen-Philips Agreement in accordance with the terms and conditions of such section. During the period commencing on the Closing Date and ending [***] thereafter, SPE shall deposit and maintain in
escrow all source code within the Licensed Luna IP (and documentation, libraries, tools, utilities and other related materials reasonably necessary for the installation, testing, deployment, operation, modification or use of such software source
code) in SPE’s possession and under SPE’s control for software necessary to operate Products within the Licensed Fields and using FOSSL Technology, as imaged on a hard drive (collectively, “Source Code Materials”) with
[***] (or, if [***] is not reasonably available, with another reputable software escrow company to be mutually agreed by the Parties). 
 CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

 5.1        During such
period, SPE shall periodically update such Source Code Materials with the latest versions thereof in SPE’s possession and under SPE’s control. 
 5.2            During such period, the Source Code Materials shall be released to Philips in the event of the bankruptcy, liquidation or
insolvency of Hansen or an assignment for the benefit of creditors by Hansen, or in the event that Philips requires access to the Source Code Materials to comply with any governmental request. In addition, unless otherwise provided for separately in
an agreement between Hansen and Philips, if Philips requests modifications to software licensed hereunder, including without limitation bug fixes or additional functionality requested by Philips, and Hansen refuses to perform the development,
maintenance or support of such software requested by Philips at Hansen’s standard rates or other reasonable and customary terms (it being understood that Hansen has no obligation to do so), then SPE shall cause the release of the applicable
portion of the software to Philips. Philips shall protect the confidentiality of any source code made available to it hereunder with the same degree of care it uses to protect its own source code and in any event no less than reasonable care.

 5.3            All fees and expenses
payable to [***] (or such other escrow company, if any) for the establishment and maintenance of such escrow arrangement under the Escrow Agreement shall be borne and paid by Philips. 

6.          Prosecution, Maintenance, and Enforcement. The rights of each of
Philips and SPE to prosecute, maintain and enforce the Licensed Luna Patents shall (solely for ease of reference and convenience) be as set forth in Sections 9.2, 9.4, 9.5, 12.1, 12.2, 12.5, 12.6 and 12.7 of the Hansen-Philips Agreement, with
references to Hansen in such sections deemed references to SPE, mutatis mutandis.  

7.           Representations, Warranties and Covenants 

7.1        Upon the reasonable request of Philips, SPE shall use
commercially reasonable efforts to enforce the representations and warranties and covenants received by Hansen in the Hansen-Luna Agreement for which Philips presents reasonable evidence of a breach thereof in such notice and which breach would have
a material and adverse effect on Philips’ rights hereunder; provided, however, that SPE shall not be obligated to enforce such representations and warranties and covenants to the extent SPE or Hansen reasonably determines it has legitimate
concerns that such enforcement will have a significant adverse impact on the other benefits and rights Hansen or SPE receives from Luna under the Hansen-Luna Agreement and/or the Development and Supply Agreement. 

CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS. 

 7.2        Notwithstanding
the foregoing, should any bankruptcy, insolvency or other creditor arrangement or proceedings be commenced by or against Luna (“Luna Proceedings”), the parties acknowledge and agree that SPE shall diligently enforce its rights and
remedies under the Hansen-Luna Agreement to the extent such rights are related to those rights and remedies granted to Philips by SPE under the terms of this Agreement, including, but not limited to, those rights arising under Section 365(n) of
the Bankruptcy Code. In so doing, SPE shall consult with Philips and consider Philips’ comments therefor in good faith. To the extent the SPE fails to enforce any such rights and remedies, SPE consents to Philips’ participation in such
proceedings along with SPE at Philips’ sole cost and expense. 

7.3        SPE represents and warrants that, as of the Effective Date:

 7.3.1    SPE has the full and unrestricted right and necessary power and
authority to execute and deliver this Agreement, grant the rights granted herein and consummate the transactions contemplated hereby. 
 7.3.2    SPE is in compliance in all material respects with the Hansen-Luna Agreement. SPE is not and to SPE’s knowledge Luna is not in material breach or default under the
terms of the Hansen-Luna Agreement, which default would have an adverse effect on Philips’ rights hereunder, and to SPE’s knowledge there exists no event, condition or occurrence which would constitute such a breach or default by SPE, nor
has SPE received any notice of any breach or default or alleged breach of default under the Hansen-Luna Agreement. The Hansen-Luna Agreement is not subject to any Third Party lien, charge, security interest or other encumbrance except as may be set
forth in the terms and conditions of the Hansen-Luna Agreement. SPE has not waived or allowed to lapse any of its rights under the Hansen-Luna Agreement, and no such rights have lapsed or otherwise expired or been terminated that would have an
adverse effect on the rights granted to Philips and its Affiliates hereunder. 

7.3.3    The execution and delivery by SPE of this Agreement or any other instrument or
document required by this Agreement do not, and the performance of this Agreement, including, without limitation, the granting of licenses granted hereunder, will not, (a) conflict with or violate the organizational documents of SPE,
(b) conflict with or violate any law, order or regulation applicable to SPE, or (c) result in any breach or violation of or constitute a material default under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of a lien, charge, security interest or encumbrance in favour of any Third Party on any of the property or assets of SPE relating to the Hansen-Luna Agreement or this Agreement. 

 7.3.4    SPE has not granted any right, license,
or interest in, to or under the Licensed Luna IP inconsistent with the rights and licenses granted to Philips in this Agreement. 
 7.3.5    Where SPE has granted an exclusive license herein, SPE represents and warrants that it has not granted any prior licenses under the Licensed Luna IP, and will not
continue to practice within those fields except as expressly set forth herein and in the Hansen-Philips Agreement. 
 7.3.6    With the exception of the consent listed on Exhibit A, no additional consents of, or notice to, any third party is required for SPE to execute and deliver this
Agreement or under the Hansen-Luna Agreement, and neither the enforceability nor any of the terms or provisions of the Hansen-Luna Agreement will be amended or terminated by, the execution, delivery and performance of this Agreement, or the
transactions contemplated hereby. 
 7.3.7    SPE (i) has sufficient capital to
carry on its business, (ii) is able to pay its debts as they mature and (iii) is and, after giving effect to the transactions contemplated hereby, will be, solvent, and the value of its assets, at a fair valuation, is and, after giving
effect to the transactions contemplated hereby, will be, greater than all of its debts. SPE has not (i) made a general assignment for the benefit of creditors, (ii) filed any voluntary petition in bankruptcy or suffered the filing of an
involuntary petition by any creditor, (iii) suffered the appointment of a receiver to take possession of all or any portion of its assets, (iv) suffered the attachment or judicial seizure of all or any portion of its assets,
(v) admitted in writing its inability to pay its debts as they come due nor (vi) made an offer of settlement, extension or composition to its creditors generally. 

7.3.8    The terms and provisions of this Agreement were negotiated at arm’s length and
are fair, reasonable and consistent with existing market conditions. There have been discussions with other potential purchasers/licensees of the FOSSL IP (under the Hansen-Luna Agreement) and, based on those discussions of market conditions, the
terms provided for in this Agreement, including price, represent in their totality the most favorable terms available to SPE. The transactions contemplated by this Agreement are not being entered into by SPE with the intention of hindering, delaying
or defrauding any of SPE’s current or future creditors. 

7.4          SPE Covenants. SPE covenants: 

7.4.1    SPE will not amend, modify, or waive the SPE-Hansen Agreement or the Hansen-Luna
Agreement in a way that would be inconsistent with any term of this Agreement. 

7.4.2    SPE will keep in full force and effect the SPE-Hansen Agreement and the Hansen-Luna
Agreement, materially comply with SPE’s obligations under such agreements, and not reduce any of its rights under such agreement in a way that would be inconsistent with any term of this Agreement. 

 7.4.3    SPE shall comply with each and every
covenant contained in Article 7 of the Limited Liability Company Agreement of ECL7, LLC (as may be amended from time to time). 
 7.4.4    SPE shall comply with all obligations under the Administrative Services Agreement described in Section 2.8. 

7.5        Closing Conditions 

7.5.1    Sublicense Agreement. SPE shall execute and deliver to Philips this Agreement and
SPE shall have complied with all obligations to be complied with by SPE on or prior to the Closing Date under this Agreement on or prior to the Closing Date. 
 7.5.2    Security Agreement. SPE shall have executed and delivered to Philips the Security Agreement and SPE shall have complied with all obligations to be complied with by SPE
on or prior to the Closing Date under the Security Agreement on or prior to the Closing Date. 

7.5.3    IP Security Agreement. SPE shall have executed and delivered to Philips the IP
Security Agreement and SPE shall have complied with all obligations to be complied with by SPE on or prior to the Closing Date under the IP Security Agreement on or prior to the Closing Date. 

7.6        Disclaimer. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 7,
ANY AND ALL LICENSED LUNA IP, CONFIDENTIAL INFORMATION, TECHNOLOGY AND INTELLECTUAL PROPERTY (AND ANYTHING ELSE) LICENSED, DISCLOSED OR PROVIDED BY EITHER PARTY TO THE OTHER PARTY IN CONNECTION WITH THIS AGREEMENT SHALL BE ON AN “AS IS”
BASIS, WITHOUT ANY REPRESENTATION OR WARRANTY WHATSOEVER. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 7, ANY AND ALL REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO ANY AND ALL WARRANTIES
RELATED TO MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ABSENCE OF ERRORS AND/OR BUGS, ACCURACY OR COMPLETENESS OF RESULTS, VALIDITY, SCOPE OR NON-INFRINGEMENT OF ANY INTELLECTUAL PROPERTY RIGHT, ARE EXPRESSLY DISCLAIMED. 

8.          Reporting 

8.1        SPE shall comply with, and support Hansen’s compliance
with, all obligations under Article 8 of the Hansen-Philips Agreement. SPE shall comply with the reporting and delivery obligations by making the required reports and delivering the required FOSSL Technology to Philips. 

8.2        For the avoidance of doubt, SPE will not object to a designee
of Philips attending, the CTO meetings specified in Section 2.3(f) of the Hansen-Luna Agreement; provided, however, that Philips’s right to attend each such meeting shall be subject to the execution of appropriate confidentiality
agreements and Luna’s prior written consent (in Luna’s sole discretion) with respect to each meeting. 

 9.        Term and Termination 

9.1        Term; Effect of Termination. This Agreement is made effective
as of the Effective Date and shall remain in force until the expiration date of the last to expire Licensed Patent (the “Term”), unless terminated earlier pursuant to this Section or termination of the Hansen-Luna Agreement, at which time
this Agreement shall terminate. 
 9.2        Termination.

 9.2.1    Unless agreed to otherwise in writing in advance by the Parties, the
termination of the Hansen-Philips Agreement by a party to such agreement for a particular reason shall automatically and without any action required by the Parties terminate this Agreement as if for the same reason and any elections made with
respect to termination by the terminating party under the Hansen-Philips Agreement shall be deemed elections made with respect to termination of this Agreement, mutatis mutandis and with references to Hansen interpreted as references to SPE.
By way of non-limiting example, if Philips terminates the Hansen-Philips Agreement pursuant to Section 13.2.1 of the Hansen-Philips Agreement and makes the election specified in Section 13.2.2(ii)(1) of the Hansen-Philips Agreement, Philips
shall be deemed to have terminated this Agreement pursuant to Section 9.2.1 and to have made the election specified in Section 9.2.2(ii)(1). Without limiting the foregoing, this Agreement (and with respect to Section 9.2.1(iii), any
part of this Agreement relating to the subject matter acquired by the non-practicing entity) may be terminated: 

(i)        by a Party in the event of a material breach of the Agreement by the
other Party which has not been cured within [***] of notice by the non-breaching Party. 

(ii)        [***]. 

(iii)        [***] 

Such rights of termination shall not be exclusive of any other surviving provisions, remedy or means of redress to which
the non-defaulting Party may be lawfully entitled and all such remedies shall be cumulative. 

9.2.2    In addition, the following shall apply: 

(i)                Termination of this
Agreement by SPE for any reason other than failure of Philips to make the full payments pursuant to Section 3.1 of this Agreement and Section 3.2 of the Hansen-Philips Agreement shall not result in the termination of any of the licenses
granted hereunder, but shall entitle SPE to bring a claim for money damages arising from Philips’ uncured material breach. 
 (ii)                In case of termination of this Agreement by Philips, Philips shall have the right to elect by written
notice either (1) to terminate all licenses granted by the Parties to each other hereunder, effective from the termination date, and to return all purchased Intellectual Property, Technology, items and licensed rights and materials hereunder to
SPE (and such licenses shall terminate and Philips shall comply with its obligations to return the foregoing), with reservation of the right to claim damages arising from the uncured material breach or (2) to maintain all such licenses and
transfers of ownership interests in full force and effect subject to the payment obligations in Section 3.2 and Section 3.3, but with reservation of its right to damages arising from the uncured material breach. 

(iii)                Termination shall
not release either Party from any payment or other obligation that has accrued as of the effective date of the termination. Without limiting the generality of the foregoing, each Party shall pay the other, within thirty (30) days after such termination, amounts equal to all reimbursable expenses, patent royalties, milestone payments and other payments of whatever nature which are then owed to such Party
hereunder. 
 CERTAIN INFORMATION HAS BEEN OMITTED AND
FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS 

(iv)                Upon termination of
this Agreement by Philips pursuant to Section 9.2.1, if Philips makes the election specified in 9.2.2(ii)(1): (1) all licenses granted by SPE to Philips pursuant to Section 2 shall automatically terminate (2) Philips may, if it deems
appropriate as contributing to the mitigation of damages, promptly prepare, execute, deliver, transfer and assign to SPE all regulatory filings and marketing authorizations covering FOSSL Systems (and related Products) for the Licensed Fields,
including any rights of reference necessary or appropriate in connection therewith; (3) Philips may, if it deems appropriate as contributing to the mitigation of damages, transfer to SPE all data, materials, results and other information
generated by or for Philips in support of regulatory approval for FOSSL Systems (and related Products) for the Licensed Fields prior to the date of such termination; (4) Philips shall cease using and, within thirty (30) days after
termination, return (and cause its Affiliates and its and their licensees and sublicensees to cease using and to return) to SPE all SPE Confidential Information provided to Philips by SPE pursuant to this Agreement and marked as such;
(5) Philips may, if it deems appropriate as contributing to the mitigation of damages, grant to SPE a nonexclusive, irrevocable, perpetual license (with the right to sublicense through one or multiple tiers) to any and all FOSSL Technology (and
any IP therein or thereto) owned or controlled by Philips as of the effective date of such termination and developed, made, created, conceived, reduced to practice (in whole or in part) by or for Philips or its Affiliates or its or their licensees
or sublicensees in connection with the exercise of the licenses granted to Philips and its Affiliates hereunder; and (6) Philips automatically shall be deemed to have assigned to SPE all Naked Licenses and Naked Sublicenses (or other
sublicenses of FOSSL IP hereunder) existing as of the effective date of termination unless SPE declines such assignment within thirty (30) days of termination. 

(v)                Without limiting the
foregoing, upon termination by Philips pursuant to Section 9.2.1(ii), the following provisions will terminate immediately upon payment by Philips to SPE or its acquirer of [***]: Section 3.2, (Product Payments, reporting requirements, and
certain sections related thereto, e.g., 3.4, 3.6, 3.14 and 3.15 of the Hansen-Philips Agreement); and any Naked Sublicenses (under Section 3.3) granted after the transaction contemplated by Section 9.2.1(ii). For the avoidance of doubt,
all Naked Sublicenses existing prior to the transaction contemplated in Section 9.2.1(ii), shall remain in force. 
 9.2.3    Certain Effects for Termination by SPE. Upon termination of this Agreement by SPE pursuant to Section 9.2 for failure of Philips to make the full payments mentioned in
Section 3.1 of this Agreement and Section 3.2 of the Hansen-Philips Agreement (i) Philips acknowledges that no licenses shall have been granted by SPE pursuant to Section 2; and (ii) Philips shall cease using and, within
thirty (30) days after termination, return (and cause its Affiliates and its and their licensees and sublicensees to cease using and to return) to SPE all SPE Confidential Information marked as such, provided to Philips by SPE pursuant to this
Agreement. 
 CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN
REQUESTED WITH RESPECT TO THE OMITTED PORTIONS 

 9.3        Survival.

 9.3.1    The following Sections shall survive the termination or the
expiration of this Agreement for any reason and in all circumstances: 2.6, 2.8, 3.4, 3.6, 3.7, 3.8, 3.9, 3.10, 4, 7.6 and 9 through 18 (excluding Section 18.8). 

9.3.2    In addition to the Sections set forth in Section 9.3.1, the following Sections shall
survive the termination of this Agreement (a) in the event of termination of this Agreement by SPE for any other cause than failure of Philips to make the full payment mentioned in Section 3.1 or payments due under Section 3.2 and Section
3.3 or (b) in the event of termination of this Agreement by Philips and if Philips makes the election specified in Section 9.2.2(ii)(1): 3.2, 3.3, 3.5, 5, 6, and 8. Further, if the licenses granted by SPE to Philips expressly survive
termination of this Agreement as provided for above, then, for the avoidance of doubt, Sections 2.2, 2.4, 2.5 and 2.7 shall also survive together with such rights and licenses. 

10.        Indemnification 

10.1    By Philips. Philips shall indemnify, defend and hold harmless SPE, its Affiliates and
their respective directors, officers, agents and employees (the “SPE Indemnitees”) from and against any and all claims, damages, liabilities, costs, expenses or loss, including reasonable legal expenses and reasonable
attorneys’ fees (“Losses”) resulting from or arising out of suits, claims, proceedings or causes of action brought by a Third Party (each, a “Third Party Claim”) against any one or more of the SPE Indemnitees,
arising from [***] 
 10.2    By SPE. SPE shall indemnify, defend and hold harmless
Philips, its Affiliates and their respective directors, officers, agents and employees (the “Philips Indemnitees”) from and against any and all Losses resulting from or arising out of a Third Party Claim against any one or more of
the Philips Indemnitees, to the extent based on: [***] 
 10.3    Procedures. The
Party requesting indemnification (“Indemnitee”) shall give prompt written notice to the Party required to provide indemnification (“Indemnifying Party”) of any Third Party Claim, with respect to which
indemnification may be required under this Section 10, provided, however, that failure to give notice shall not impair the obligation of the Indemnifying Party to provide indemnification hereunder except if and to the extent that failure materially
impairs the ability of the Indemnifying Party successfully to defend the Third Party Claim. The Indemnifying Party shall be entitled to assume the defense and control of any Third Party Claim at its own cost and expense, but the Indemnitees shall
have the right to be represented by its own counsel at its own cost in such matters. The Indemnitees shall provide all reasonable assistance to the Indemnifying Party, at the Indemnifying Party’s expense, in connection with the defense of any
Third Party Claim hereunder. Neither Party shall settle or dispose of any Third Party Claim in any manner which would adversely impact the rights or interests of the other Party under this Agreement without the other Party’s prior written
consent, without limiting the application of the royalty-stacking provisions of Section 3.4 of the Philips-Hansen Agreement. 
 CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

 10.4    Notwithstanding anything in the
foregoing, a Party shall not be required to indemnify the other Party for any liability such other Party incurs arising from some act or omission for which such other Party is responsible under applicable law. 

11.        Bankruptcy. Notwithstanding anything to the contrary in this Agreement,
the Parties hereto acknowledge and agree that all rights, privileges, releases, non-assertions, immunities and licenses granted under or pursuant to this Agreement by SPE to Philips and its Affiliates are, and are intended to be, and shall be deemed
to be, for purposes of Section 365(n) of title 11 of the United States Code, (as may be amended from time to time, “the Bankruptcy Code”), licenses of rights to intellectual property (including without limitation “intellectual
property” as defined under Section 101(35A) of the Bankruptcy Code) and: (a) all reports, drawings, samples, prototypes and other books and records and embodiments of the intellectual property shall be deemed “embodiments”
of the intellectual property protected by Section 365 of the Bankruptcy Code hereunder; and (b) any escrow agreements established pursuant to this agreement shall be an “agreement supplementary” to this Agreement for the purposes
of Section 365(n) of the Bankruptcy Code. All of the rights of Philips and its Affiliates under this Agreement shall be deemed to exist immediately before the occurrence of any bankruptcy proceeding in which SPE is a debtor. The Parties hereto
acknowledge and agree that Philips and its Affiliates, as licensees of such rights under this Agreement, shall retain and may fully exercise all of their rights and elections under the Bankruptcy Code or equivalent law, statute, treaty or
legislation in any other jurisdiction including, but not limited to, those rights and remedies under Section 365(n) of the Bankruptcy Code. Without limiting the generality of the foregoing, SPE further agrees that, in the event that any
proceeding shall be instituted by or against SPE seeking to adjudicate it as bankrupt or insolvent, or seeking liquidation, winding up, reorganization, arrangement, adjustment, protection, relief or composition of SPE or its debts under any law
relating to bankruptcy, insolvency, or reorganization or relief of debtors, or seeking an entry of an order for relief or the appointment of a receiver, trustee or other similar official for SPE or any substantial part of its property or if SPE
shall take any action to authorize any of the foregoing actions (collectively, an “Insolvency Proceeding”), Philips and its Affiliates shall retain all rights, licenses, privileges, releases, non-assertions and immunities granted under or
pursuant to this Agreement and their rights to enforce these rights under this Agreement. Without limiting the foregoing, to the maximum extent permitted by law, Philips and its Affiliates shall not be affected by the rejection of this Agreement in
any such Insolvency Proceeding (a “Rejection”) and Philips and its Affiliates shall retain all rights and remedies as provided under Section 365(n) of the Bankruptcy Code. Upon any Rejection, SPE and/or any trustee shall be required
to turn over the intellectual property subject to this Agreement to Philips upon written request made by Philips to SPE and/or the trustee. Philips shall under no circumstances be required to terminate this Agreement after a Rejection in order to
enjoy or acquire any of its rights under this Agreement; provided, however, upon any such Rejection Philips shall have the automatic right to terminate this Agreement. In the event that this Agreement is subject to a Rejection any continuing
payments required by Philips hereunder shall be equitably adjusted to reflect the loss of any services or other rights of Phillips and its Affiliates or obligations of SPE or its Affiliates that are terminated as a result of any such Rejection.
Notwithstanding anything in this Agreement to the contrary, in the event that SPE files for relief or protection under the Bankruptcy Code, or there is otherwise an Insolvency Proceeding by or against SPE, SPE acknowledges and agrees that each and
all of the rights, licenses, privileges, non-assertions and immunities granted to Philips under this Agreement are not assumable by SPE (or a trustee) and are not assignable to a Third Party. Upon any such Insolvency Proceeding by or against SPE,
Philips shall be deemed to have made a request for enforcement of all of its rights and licenses pursuant to Section 365(n)(4) of the Bankruptcy Code, without further action by Philips. 

 12.        Confidentiality. Information
exchanged under this Agreement shall be subject to the terms and conditions set forth in Section 15 of the Hansen-Philips Agreement, which is incorporated by reference (solely for ease of reference and convenience) with references to Hansen in
such section deemed references to SPE, mutatis mutandis. 

13.        Limitation of Liability. Except for a breach of Section 12
(Confidentiality), neither Party shall be liable to the other Party, its employees, directors, shareholders, agents for any indirect or consequential, incidental, punitive or special, damages (including but not limited to damages for business
interruption or for personal injury) arising out of or in connection with this Agreement, even if the other Party has been advised of the possibility of such damages. To the extent either Party is liable to the other Party for any claims arising out
of or in connection with this Agreement, such liability shall be limited to [***]. 

14.        Notices. 

Any notice required under this Agreement to be sent by either Party shall be given in writing by means of a letter or
facsimile directed: 
 In respect of SPE, to: 

ECL7, LLC 
 800 East Middlefield Road 
 Mountain View, CA 94043 

Attention: Steve Ware 
 In respect of Philips, to: 
 Philips Intellectual
Property & Standards 
 P.O. Box 220 

5600 AE Eindhoven 
 The Netherlands 
 F.a.o. CIPO 

Fax no.: + 31 40 27 45267 
 CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

 And also to: 

Philips Healthcare 
 A division of Philips Electronics North America Corp. 
 3000
Minuteman Road 
 Andover, MA 01810 

USA 
 Attention: Chief Legal Officer 
 Fax no. : 978-975-1285 

With a copy to, for technical matters and information pursuant to Article 8: Nijs C. van der Vaart, PhD, Senior Director
Innovation, BU interventional X ray 
 Veenpluis 4-6 

5684 PB Best 
 The Netherlands 
 FAX number: +31 40 27 65657 

or such other address as may have been specified in writing by either Party to the other. Notice shall be conclusively
deemed to have been duly given (a) when hand delivered to another Party; (b) when sent by facsimile, with receipt confirmation, to the number set forth above if sent between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business
day, or on the next business day if sent other than between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business day; or (c) the next business day after deposit with an international overnight delivery service, postage prepaid,
addressed to the applicable Party as set forth above with next business day delivery guaranteed, provided that the sending Party receives a confirmation of delivery from the delivery service provider. 

15.        No Assignment 

15.1    This Agreement shall be binding upon and inure to the benefit of the Parties and their
respective successors and permitted assigns. This Agreement shall not be assignable by either Party, in whole or in part to any Third Party, except that either Party may assign or transfer this Agreement, without consent, to (a) a purchaser of
all or substantially all of such Party’s assets to which this Agreement relates or (b) a successor to such Party’s business to which this Agreement relates through any merger, consolidation or reorganization; provided in each case
that the entity to whom this Agreement is assigned agrees in writing to be bound by the terms and conditions hereof, as well as the conditions and obligations set forth in the Administrative Services Agreement, the Assignment Agreement, the Security
Agreement, the IP Security Agreement, and any other applicable agreement. 

 16.        Independent Contractors. The
Parties are and intend to remain independent contractors. Nothing in this Agreement shall be construed as an agency, joint venture or partnership between the Parties. 
 17.        Applicable Law and Jurisdiction 
 17.1    This Agreement shall be governed by and construed in accordance with the laws of New York, without regard or reference to its conflicts of law rules or principles.

 17.2    Any dispute between the Parties in connection with this Agreement
(including any question regarding its existence, validity or termination) shall be submitted to the competent courts of The State of New York. 
 18.        Miscellaneous 
 18.1    Force Majeure. If for reasons of Force Majeure, as hereinafter defined, any Party fails to comply with its obligations hereunder other than the payment of money, such
failure shall not constitute breach of contract, provided, however, that such Party shall give the other Party prompt written notice of the failure to perform and the reason therefor and uses its reasonable efforts to limit the resulting delay in
its performance. For the purpose of this Section, Force Majeure shall mean acts of God; war; civil commotion; destruction of production facilities or materials; fire, earthquake or storm; labor disturbances or strikes; failure of public utilities or
common carriers and any other similar causes beyond the reasonable control of any party. 

18.2    Severability. If any of the provisions of this Agreement is determined to be invalid
or unenforceable by any court of competent jurisdiction, such finding shall not invalidate the remainder of this Agreement which shall remain in full force and effect as if the provision(s) determined to be invalid or unenforceable had not been a
part of this Agreement. In the event of such finding of invalidity or unenforceability, the Parties will endeavor to substitute forthwith the invalid, or unenforceable provision(s) by such effective provision(s) as will most closely correspond with
the original intention of the provision(s) so voided. 
 18.3    Entire
Understanding. This Agreement and any attachments hereto constitute a single, integrated written contract expressing the entire agreement of the Parties with respect to the subject matter hereof and shall not be modified, supplemented, or
repealed except by a writing signed by each of the Parties. No covenants, agreements, representations, or warranties of any kind whatsoever have been made by any Party, except as specifically set forth in this Agreement or the Hansen-Philips
Agreement. All prior discussions, written communications, agreements and negotiations with respect to the subject matter hereof have been merged and integrated into and are superseded by this Agreement. 

 18.4    Waiver. No waiver by any of the Parties
to this Agreement of any breach of any term, condition or obligation of this Agreement by any other Party shall be construed as a waiver of any subsequent or continuing breach of that term, condition or obligation or of any other term, condition or
obligation of this Agreement of the same or of a different nature. Neither the failure nor the delay of either Party to enforce any provision of, or right or remedy under, this Agreement shall constitute a waiver of such provision, right or remedy
or of the right of each Party to enforce each and every provision of this Agreement. Any waiver of this Agreement must be in writing. 
 18.5    Authority; Due Execution. Each Party represents and warrants to the other, that (i) it has full power and authority to enter into this Agreement and any agreements
related hereto and, subject to the terms and conditions hereof, this Agreement, when executed, will be a valid and legally binding obligation of such Party according to its provisions; (ii) the execution and performance of this Agreement will
not constitute a breach of or an event of default under any agreement, contract, law or regulation to which such Party is or may be bound; and (iii) the execution and performance of this Agreement has been duly authorized by all necessary
corporate action. 
 18.6    Counterparts. This Agreement may be executed in two or
more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 18.7    Headings. The headings and captions used in this Agreement are for convenience only and shall not be considered in construing or interpreting this Agreement. 

18.8    Non-Competition. Except for Hansen Products within a Buy Back Field for which SPE
obtains rights pursuant to Section 4, during the Term of the Agreement, SPE shall not directly or indirectly develop, manufacture, distribute, sell or market any Hansen Products in the Vascular Non-Robotic Field, the Endoluminal Non-Robotic Field,
the Non-Robotic Medical Devices Field (including the Colonoscopy Non-Robotic Field), and the Orthopedics Field. To avoid doubt, the foregoing covenant shall not be read or interpreted to extend to the SDOF Medical Robotics Field and the Medical
Robotics Field. The covenant of this Section 18.8 shall not apply to any entity that acquires SPE, by a Change of Control or otherwise, or any other Affiliate of SPE following a Change of Control of SPE or its Affiliates, with respect to any
intellectual property rights that such entity owned or otherwise controlled prior to the Change of Control or after such Change of Control (other than the FOSSL IP), or with respect to any activities already done by that entity prior to the Change
of Control or after such Change of Control (other than in connection with the FOSSL IP). 

18.9    Specific Performance. The rights and remedies of the parties hereto shall be
cumulative. The transactions contemplated by this Agreement are unique transactions and any failure on the part of any party to complete the transactions contemplated by this Agreement on the terms of this Agreement will not be fully compensable in
damages and the breach or threatened breach of the provisions of this Agreement would cause the other parties hereto irreparable harm. Accordingly, in addition to and not in limitation of any other remedies available to the parties hereto for a
breach or threatened breach of this Agreement, the parties shall be entitled to seek specific performance of this Agreement and seek an injunction restraining any such party from such breach or threatened breach. 

[Remainder of Page Intentionally Left Blank] 

 AS WITNESS, the Parties have caused this Agreement to be signed on the date first written
above. 
 FOR SPE: 
 ECL7, LLC 
  

	
	 /s/ Stephen Ware

	 (signature)

	 Name: Stephen Ware

	 Title: President

 FOR
PHILIPS: 
 Koninklijke Philips Electronics N.V. 

 

	
	 /s/ Ruud Peters

	 (signature)

	 Name: Ruud Peters

	 Title: Chief Intellectual Property Officer

 Philips Medical Systems Nederland B.V. 
  

	
	 /s/ Bert Van Meurs

	 (signature)

	 Name: Bert Van Meurs

	 Title: Senior Vice President

  

	
	 /s/ John Van Soerland

	 (signature)

	 Name: John Van Soerland

	 Title: Senior Director

[SIGNATURE PAGE TO SUBLICENSE AGREEMENT BETWEEN
SPE AND PHILIPS] 

 EXHIBIT A 
 List of Consents 
 NoneAssignment and License Agreement between Hansen and SPE

 Exhibit 10.70 
 ASSIGNMENT AND LICENSE AGREEMENT BETWEEN HANSEN AND SPE 

This Assignment And License Agreement Between Hansen and SPE (“Agreement”) is dated and made effective
as of February 3, 2011 (the “Effective Date”) by and between ECL7, LLC, a Delaware limited liability corporation, (“SPE”) and Hansen Medical, Inc., a Delaware corporation (“Hansen”). SPE and
Hansen are referred to individually as a “Party” and collectively as the “Parties.” 

RECITALS 
 WHEREAS, Luna (as defined below) and Hansen entered into that certain License Agreement Between Hansen and Luna (“Hansen-Luna Agreement”), with an
effective date of January 12, 2010, in which, among other things, Luna granted a license to Hansen to certain intellectual property related to fiber optic shape sensing or localization technologies. 

WHEREAS, Hansen wishes to assign and convey to its affiliate, SPE, the Hansen-Luna
Agreement, and SPE wishes to accept such assignment, subject to the terms and conditions of this Agreement. 

WHEREAS, contemporaneously with such assignment, the Parties desire for SPE to grant
Hansen certain of SPE’s rights under the assigned Hansen-Luna Agreement, including those relating to the Medical Robotics Field such that Hansen can fully exercise such rights in accordance with the terms and conditions of the Hansen-Luna
Agreement and this Agreement. 
 WHEREAS, SPE and Koninklijke Philips
Electronics N.V. and Philips Medical Systems Nederland B.V. (“Philips”) intend to enter into that certain Sublicense Agreement Between SPE and Philips (“SPE-Philips Agreement”), with effective date of
February 3, 2011, setting forth the terms and conditions governing, among other things, the grant of a sublicense from SPE to Philips to practice under certain patents and other intellectual property related to FOSSL Technology licensed from
Luna under the Hansen-Luna Agreement in certain medical fields. 
 WHEREAS,
Hansen and Philips entered into that certain Patent and Technology License and Purchase Agreement between Hansen and Philips (“Hansen-Philips Agreement”), dated as of the date hereof, setting forth the terms and conditions
governing, among other things, the grant of a license from Hansen to Philips to practice under the patents and other intellectual property related to FOSSL Technology in certain medical fields. 

NOW, THEREFORE, in view of the terms and conditions described below
and for other valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereto agree as follows: 
 AGREEMENT 

1.          Definitions 

Unless otherwise defined in this Agreement, initially capitalized words and phrases shall have the meanings given to them
in the Hansen-Luna Agreement. References to “Sections” are references to sections of this Agreement unless expressly stated otherwise. 
 2.          Assignment 
 2.1        Assignment. Subject to and conditioned upon the terms and conditions of this Agreement, in accordance with Section 6.3 of the
Hansen-Luna Agreement (permitting Hansen to assign to an Affiliate the Hansen-Luna Agreement along with the rights granted thereunder without Luna’s consent), Hansen hereby sells, assigns and conveys to SPE, without recourse (except to the
extent set forth in this Agreement), the entire right, title and interest of Hansen in and to the Hansen-Luna Agreement, together with all of Hansen’s rights, powers, privileges, benefits, causes of action, and remedies arising under the
Hansen-Luna Agreement, except to the extent of the Excluded IP, as defined in Section 3.5 (collectively, the “Assigned Interest”). Such assignment is effective as of the Effective Date. SPE hereby accepts such assignment and
assumes the Hansen-Luna Agreement as “Hansen” thereunder. SPE hereby assumes and agrees to observe and perform all of the duties, obligations, terms, provisions and covenants, and to pay and discharge all of the liabilities of
“Hansen” thereunder to be observed, performed, paid or discharged from and after the Effective Date, except to the extent of the Hansen Licensed IP (collectively, the “Assumed Liabilities”). Following this assignment, the
party in privity with Luna under the Hansen-Luna Agreement, and having the exclusive right to make decisions as “Hansen” thereunder (except to the extent of the Hansen Licensed IP), shall be SPE and not Hansen. 

 2.2        Payment. SPE and
Hansen agree that the fair market value of, and purchase price for, the Assigned Interest equals [***]. SPE shall pay the purchase price by paying to Hansen, within five business days after the date hereof, [***] thereof in immediately available
funds in cash, to such account as shall be designated to SPE by Hansen. 

2.3        True Sale. 

(a)        SPE and Hansen intend that the assignment from Hansen to SPE under
Section 2.1 is and shall constitute an absolute and unconditional sale to SPE from Hansen of all of Hansen’s right, title and interest in and to the Assigned Interest, and not a loan. SPE and Hansen agree that each would suffer irreparable
harm from treatment of the assignment of the Assigned Interest pursuant to Section 2.1 as anything other than a true sale by Hansen to SPE of the Assigned Interest. SPE and Hansen agree to treat the assignment of the Assigned Interest under
Section 2.1 for all purposes (including without limitation tax and financial accounting purposes) as a sale to SPE on all relevant books, records, financial statements and other applicable documents, and respond to any third party inquiries
relating to the ownership of any of the Assigned Interest by stating that such Assigned Interest has been sold. 
 (b)        In the event that, notwithstanding the intent of SPE and Hansen to the contrary, the assignment under Section 2.1 is for any reason deemed by a
court of competent jurisdiction not to constitute an absolute and unconditional sale of the Assigned Interest to Purchaser, (i) SPE and Hansen agree that such assignment shall be deemed to constitute the grant of a valid and continuing security
interest by Hansen to SPE in all right, title and interest of Hansen in and to the Assigned Interest and (i) Hansen covenants and agrees (A) not to permit or suffer to exist any claims, liens or encumbrances upon the Assigned Interest,
other than by, through or under SPE or its successors or assigns, and (B) not to sell, mortgage, pledge or otherwise hypothecate the Assigned Interest. This Agreement shall constitute a security agreement under applicable law if the assignment
under Section 2.1 is deemed not to constitute a sale. Hansen hereby authorizes SPE to file any and all financing statements necessary to perfect the grant of such security interest under the applicable Uniform Commercial Code or to maintain
perfection thereof; provided, however, that prior to making any such filing, SPE shall submit a draft of such filing to Hansen for its review and approval. No such filing or other action under or pursuant to this Section 2.3(b) shall be
construed to prejudice the intent of SPE and Hansen that the assignment pursuant to Section 2.1 constitute an absolute and unconditional sale. 
 3.          Intellectual Property Rights 
 3.1        Rights under Hansen-Luna Agreement. For purposes of clarification only, Hansen, as an Affiliate of SPE (after giving effect to SPE’s receipt
of the Assigned Interest), is a recipient of the license granted by Luna in the Medical Robotics Field in Section 2.1 of the Hansen-Luna Agreement pursuant to the language stating “Luna hereby grants to Hansen and its Affiliates [. .
..].” Generally and without limiting the foregoing, in such capacity, Hansen shall be entitled to all the rights and licenses afforted to Affiliates under the Hansen-Luna Agreement. Hansen acknowledges and agrees that such rights of Hansen under
the Hansen-Luna Agreement as an Affiliate of SPE are subject to the rights granted by SPE to Philips pursuant to the SPE-Philips Agreement for so long as and to the extent such rights are in effect (the “Philips Rights”).

 CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH
RESPECT TO THE OMITTED PORTIONS. 

  
 2 

 3.2        License Grants by SPE
to Hansen. 
 (a)        Right to Sublicense in Medical Robotics
Field. SPE hereby grants to Hansen the exclusive right to sublicense (through one or multiple tiers) Licensed IP in the Medical Robotics Field solely (A) in connection with the development, manufacture, use or sale of Hansen Products,
(B) with respect to SDOF Medical Robotics for which Hansen will have the sole right to grant naked sublicenses to third parties (without any restrictions or interference from either Intuitive or Luna or SPE) and Intuitive has no right to grant
such naked sublicenses, and/or (C) as otherwise mutually agreed by Intuitive and Hansen and Luna. 

(b)        General Grant by SPE. To the fullest extent permitted by the
Hansen-Luna Agreement and to the extent not granted in Section 3.2(a), SPE hereby hereby grants to Hansen the right to exercise any and all rights and licenses of SPE under the Hansen-Luna Agreement other than the Philips Rights. Without
limiting the foregoing, and in each case subject to the Philips Rights: 

(i)        Prosecution, Maintenance and Enforcement of Licensed Patents.
Hansen shall have, and SPE hereby grants to Hansen, all rights to prosecute, maintain and enforce the Licensed Patents that are held by SPE with respect to the Medical Robotics Field under Sections 5.1 and 5.2 of the Hansen-Luna Agreement. Hansen
shall receive the benefit of all rights and recoveries obtained in connection with enforcement actions therefor. 
 (ii)        Full Exercise of Rights in the Medical Robotics Field. To the extent not already provided for herein, SPE hereby grants and agrees to grant and
provide to Hansen any and all rights and privileges, and to perform any and all services, necessary for Hansen to fully exercise the rights and privileges of SPE under the Hansen-Luna Agreement for the Medical Robotics Field relating to the Licensed
IP and/or any FOSSL Technology. 
 (iii)        Other Rights. To
the extent not within the Philips Rights and to the extent not already provided for herein, (a) SPE grants Hansen the right to sublicense (through one or multiple tiers) the Licensed IP outside the Medical Robotics Field to the full extent
authorized by the Hansen-Luna Agreement and SPE shall grant any sublicenses authorized under the Hansen-Luna Agreement at and in accordance with Hansen’s direction if and to the extent Hansen cannot itself grant such a sublicense; (b) SPE
grants Hansen the full rights to enjoy the benefits of Sections 2.2(a) and 2.3(e) regarding Luna’s agreement that Hansen owns certain intellectual property; (c) SPE grants and agrees to afford Hansen the benefits of the technology
disclosures from Luna and related provisions of Section 2.3(f) and to follow Hansen’s directions with respect thereto; and (d) for the avoidance of doubt, if and to the extent any rights arising from the Hansen-Luna Agreement and
granted to Philips under the SPE-Philips Agreement terminate, lapse, revert, are bought back or are otherwise returned to SPE, such rights shall thereupon immediately be included in the grants to Hansen provided for in this Section 3.2(b)(ii).

 (iv)        Clarification Regarding Copyrights. With respect
to Technology sublicensed by SPE to Hansen under this Section 3.2 that includes software, works or authorship or copyrighted materials, such licenses shall include the right to copy, modify and make derivative works thereof (and the right to
use any ideas, concepts, algorithms and other information contained therein) within the fields and pursuant to the terms and conditions otherwise provided in this Agreement, regardless of when or whether provided or disclosed to Hansen. The
foregoing shall not be construed to require the delivery or provision of any particular software (or source code), works of authorship or copyrighted materials except to the extent specifically provided in one or more separate written agreements
between the Parties. 

  
 3 

 3.3        Third Party License
Payments and Agreement Terms. SPE hereby assigns and delegates to Hansen, and Hansen hereby assumes and agrees to discharge, all of the Assumed Liabilities with respect to Third Party Payments (as defined below) from and after the Effective
Date. If Hansen’s practice of Licensed IP (including through Hansen’s manufacture, use or sale of Products covered thereby or grant of a sublicense covered thereby) that is in-licensed by Luna from third party licensors and sublicensed to
Hansen under Section 2.1 of the Hansen-Luna Agreement (Luna’s licenses of such third party Licensed IP being “Third Party Licenses” and such third party licensors being “Third Party Licensors”), results in
a royalty, milestone or similar payment becoming due to any Third Party Licensors, Hansen shall be responsible for such payments (such payments attributable to Hansen’s practice of Licensed IP being, “Third Party Payments”).
Pursuant to Section 3.2, in connection with such Third Party Licenses and Third Party Payments, Hansen shall have all the rights and obligations of SPE vis-à-vis Luna set forth in Section 2.4 of the Hansen-Luna Agreement.

 3.4        [***] 

3.5        Clarification Regarding Hansen IP. With respect to any
intellectual property of Hansen that is licensed to Luna under the Hansen-Luna Agreement (namely the Hansen Licensed IP) prior to the assignment of such agreement hereunder, such intellectual property (the “Excluded IP”) shall
remain subject to such license in accordance with the applicable terms and conditions of the Hansen-Luna Agreement following such assignment hereunder. 
 3.6        Cooperation by SPE. SPE shall provide Hansen any and all cooperation and assistance requested by Hansen to enable Hansen to perform Hansen’s
obligations and exercise and enforce Hansen’s rights under the Hansen-Luna Agreement (as an Affiliate of SPE or as a result of this Agreement and subject to the Philips Rights), the Hansen-Philips Agreement, Development and Supply Agreement,
that certain Cross License Agreement Between Intuitive and Hansen dated January 12, 2010 between Hansen and Intuitive Surgical, Inc, and this Agreement. Without limiting the foregoing, SPE shall provide to Hansen all communications, notices and
information received by SPE from Luna (and Intuitive and Philips) in connection with such agreements, and, if requested by Hansen, SPE shall provide any requested communications, notices and information to Luna (and Intuitive and Philips) in
connection with such agreements. 
 3.7        Source Code
Escrow. Without limiting Section 3.6, SPE shall deliver to [***] any source code within the Licensed Luna IP in SPE’s possession or control for inclusion pursuant to the Source Code Escrow provisions of Section 5 of the
Hansen-Philips Agreement. 
 4.          Representations and
Warranties. 
 4.1        By Hansen. Hansen hereby represents
and warrants as follows: 
 4.1.1    Hansen is a corporation duly organized, validly
existing and in good standing under the laws of the state of Delaware. 

4.1.2    The execution, delivery and performance of this Agreement by Hansen (i) are
within its corporate powers, (ii) have been duly authorized by all necessary corporate action on Hansen’s part, and (iii) do not and shall not contravene or constitute a default under any law or regulation, any judgment decree or
order, or any contract, agreement or other undertaking applicable to Hansen. 
 CERTAIN INFORMATION HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS 

  
 4 

 4.1.3    Hansen is the legal and beneficial
owner of the Assigned Interest and the Assigned Interest is free and clear of any lien, encumbrance or other adverse claim. All notices, consents and approvals required for the effectiveness of the assignment under Section 2 have been made or
obtained and are in full force and effect. 
 4.2        By SPE.
SPE hereby represents and warrants as follows: 
 4.2.1    SPE is a limited
liability corporation duly organized, validly existing and in good standing under the laws of the state of Delaware. 
 4.2.2    The execution, delivery and performance of this Agreement by SPE (i) are within its corporate power, (ii) have been duly authorized by all necessary corporate
action on SPE’s part, and (iii) do not and shall not contravene or constitute a default under any law or regulation, any judgment, decree or order, or any contract, agreement or other undertaking applicable to SPE. 

4.2.3    SPE has the full right and authority to grant the rights and licenses granted to
Hansen under Section 3 herein. 

4.3        Disclaimer. EXCEPT AS EXPRESSLY PROVIDED FOR IN THIS AGREEMENT,
NEITHER PARTY MAKES ANY, AND EACH PARTY EXPRESSLY DISCLAIMS ALL, REPRESENTATIONS AND WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, WITH RESPECT TO THE SUBJECT MATTER OF THIS AGREEMENT, INCLUDING WITHOUT LIMITATION WARRRANTIES OF MERCHANTABILITY AND
FITNESS FOR A PARTICULAR PURPOSE. 
 5.          Miscellaneous

 5.1        Entire Agreement. This Agreement (and the
documents referenced herein) contains the entire agreement and understanding of the Parties with respect to the subject matter hereof, and supersedes and merges all prior and contemporaneous understandings and agreements between the Parties, whether
written or oral, with respect to such subject matter. This Agreement shall not be modified, amended or cancelled other than in a writing signed by authorized representatives of SPE and Hansen. 

5.2        No Implied Waiver. Any waiver of any obligation under this
Agreement must be in writing. The failure of any Party to enforce at any time any provision of or right under this Agreement shall not be construed to be a waiver of such provision or right or any other provision, and shall not affect the right of
such Party to enforce such provision or right or any other provision. No waiver of any breach hereof shall be construed to be a waiver of any other breach. SPE shall follow Hansen’s directors (at Hansen’s expense) with respect to any
enforcement of the Hansen-Luna Agreement in connection with any of the foregoing and Hansen shall be entitled to receive and retain the proceeds and/opr the benefit of any other remedies from any such enforcement. 

5.3        Assignment. This Agreement and the rights of the Parties
hereunder may not be assigned by a Party without the prior written consent of the other Party; provided, however, this Agreement (along with the rights granted under this Agreement) may be assigned by Hansen without SPE’s consent to an
Affiliate or as part of (i) a merger, consolidation, internal reorganization, or acquisition of Hansen or (ii) a sale of all or substantially all the assets of Hansen. Subject to the foregoing, the respective obligations of the Parties
hereto shall bind, and the respective rights of the Parties shall inure to the benefit of, the Parties’ respective permitted assignees and successors. For the avoidance of doubt, any assignment or transfer of the Hansen-Luna Agreement or any
rights thereunder shall only be made fully subject to the terms and conditions of this Agreement. 

  
 5 

 5.4        Governing Law;
Jurisdiction; Venue. This Agreement shall be governed by, and interpreted in accordance with, the laws of the State of California, without regard to conflicts of laws, or applicable federal law as to a particular subject where federal law
governs, such as for example, the Patent Act governing patents or the Copyright Act governing copyrights. Each Party hereby (i) consents and submits to the venue and co-exclusive jurisdiction of the courts of New Castle County in the State of
Delaware and the Federal courts of the United States sitting in such part of the District of Delaware, (ii) agrees that all claims may be heard and determined in such courts, (iii) irrevocably waives (to the extent permitted by applicable
law) any objection that it now or hereafter may have to the laying of venue of any such action or proceeding brought in any of the foregoing courts, and any objection on the ground that any such action or proceeding in any such court has been
brought in an inconvenient forum, and (iv) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner permitted by law. Each of the
Parties hereby consents to service of process by any party in any suit, action or proceeding in accordance with such applicable law. 
 5.5        Severability. If for any reason a provision of this Agreement, or portion thereof, is finally determined to be unenforceable under applicable law,
that provision, or portion thereof, shall nonetheless be enforced, as to circumstances, persons, places and otherwise, to the maximum extent permissible by applicable law so as to give effect to the intent of the parties, and the remainder of this
Agreement shall continue in full force and effect. 

5.6        Confidentiality. Confidential information within the Licensed
IP shall be subject to the terms and conditions of the confidentiality provisions set forth in Section 6.7 of the Hansen-Luna Agreement. 
 5.7        Headings. The headings and captions used in this Agreement are for convenience only and shall not be considered in construing or interpreting this
Agreement. 
 5.8        Interpretation. This Agreement has been
negotiated by all parties, and each Party has been advised by competent legal counsel. This Agreement shall be interpreted in accordance with its terms and without any construction in favor of or against any Party. 

5.9        Counterparts. This Agreement may be executed in counterparts,
each of which shall be deemed an original, but which collectively shall constitute one and the same instrument. 

5.10          Notices. Except as may be otherwise provided
herein, all notices, requests, waivers, consents and approvals made pursuant to this Agreement shall be in writing and shall be conclusively deemed to have been duly given (a) when hand delivered to another Party; (b) when sent by
facsimile, with receipt confirmation, to the number set forth below if sent between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business day, or on the next business day if sent by facsimile to the number set forth below if sent other
than between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business day; or (c) the next business day after deposit with a national overnight delivery service, postage prepaid, addressed to the applicable Parties as set forth below
with next business day delivery guaranteed, provided that the sending Party receives a confirmation of delivery from the delivery service provider. Each person making a communication hereunder by facsimile shall attempt to promptly confirm by
telephone to the person to whom such communication was addressed each communication made by it by facsimile pursuant hereto but the absence of such confirmation shall not affect the validity or delivery status of any such communication. A Party may
change or supplement the addresses given below, or designate additional addresses, for purposes of this Section by giving the other Parties written notice of the new address in the manner set forth above. 

  
 6 

					
	 If to Hansen Medical, Inc.
	  			
	               800 E. Middlefield Road
	  			
	               Mountain View, CA 94043
	  			
	               Attn: Arthur Hsieh
	  			
	               Email:
Arthur_Hsieh@hansenmedical.com
	  			
		
	 If to SPE
	  			
	               800 E. Middlefield Road
	  			
	               Mountain View, CA 94043
	  			
	               Attn: Steve Ware
	  			
	               Email:
Steve_Ware@hansenmedical.com
	  			

 5.11      Further Assurances. Each Party
agrees to take or cause to be taken such further actions, and to execute, deliver and file or cause to be executed, delivered and filed such further documents and instruments, and to obtain such consents, as may be reasonably required or requested
by the other Party (to the extent consistent with this Agreement and at the other Party’s expense) in order to effectuate fully the purposes, terms and conditions of this Agreement. Without limiting the foregoing, each Party shall take such
steps reasonably requested by the other Party to perfect, and provide constructive notice of, the licenses and other rights granted to such Party hereunder, including without limitation filings in any governmental office where that is customary or
appropriate in accordance with applicable law. 
 5.12      Non-Petition.
Prior to the Basic Documents Termination Date (as defined in the LLC Agreement of SPE), Hansen agrees, solely in its capacity as a creditor of SPE, not to acquiesce, petition or otherwise invoke or cause SPE to invoke the process of any court or
governmental authority for the purpose of commencing or sustaining a case against SPE under any federal or state bankruptcy, insolvency or similar law or appointing a receiver, liquidator, assignee, trustee, custodian, sequestrator or other similar
official of SPE or any substantial part of the property of SPE, or ordering the winding up or liquidation of the affairs of SPE. 

[Remainder of Page Intentionally Left Blank] 

  
 7 

 IN WITNESS
WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date. 
  

					
	 HANSEN MEDICAL, INC.
	 		  	 ECL7, LLC

			
	 By: /s/ Bruce J Barclay
	 		  	 By: /s/ Stephen Ware

			
	 Name: Bruce J Barclay
	 		  	 Name: Stephen Ware

			
	 Title: Chief Executive Officer
	 		  	 Title: President

[ASSIGNMENT AND LICENSE AGREEMENT]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}]]